Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water24/7 Wall Street • 10/01/26
Moderna Stock Slumps as Citi Says It's Time to Sell After 500% Rally This YearInvestopedia • 09/30/26
4 Winning Single-Stock Leveraged ETF Areas of First Nine Months of 2026Zacks Investment Research • 09/28/26
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth KnowingZacks Investment Research • 09/25/26